about
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative DiseasesCannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts.Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.Endocannabinoid signalling in innate and adaptive immunity.Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.The role of reticulons in neurodegenerative diseases.Novel targets in multiple sclerosis: to oxidative stress and beyond.Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.Bioactive lipids as modulators of immunity, inflammation and emotions.Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors.Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor.Endocannabinoids and Immunity.The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptorsProresolving Lipid Mediators: Endogenous Modulators of Oxidative StressErratum to "Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress"
P50
Q26765787-5AE86B83-5CA3-455E-933A-3B186F3215CEQ30661637-8451188F-FC45-4CBC-858D-B40595EEFBD4Q33418879-91808C7D-178B-42BC-879E-D8BEBE181040Q33526286-99EEEEFC-2127-407D-9649-7B4BA2AC5589Q34458059-747D035F-578C-4936-87DE-B545EDD79ECAQ35602343-94A20CCA-4CC3-4CD2-A1BF-73FA8AD52025Q35987617-267EA484-6194-4290-97EB-F170744BACDAQ38146313-E8EC30D4-3E45-4F75-8C1F-9F074B8EECB7Q38161870-E828603E-F245-48EA-B795-A6A0BCC99EA9Q38283708-F78F39E6-FA5A-48A2-BB8C-49A7018AAF86Q38324480-C267DB26-2C1A-4CB6-A62A-F32F335CF340Q38884460-56FF7833-D233-4B2C-A7C3-9499DDBEFF45Q38935916-7F647C66-CB62-41BC-BFEC-5E8F75709E15Q39023817-B072E363-8197-4BD8-B2E5-B8D2ED7D16E6Q41560698-F07510CB-2610-42AF-B8A3-DF9F57FC99F3Q48475306-BC6A76D4-EFF8-467C-8B17-BE6634556039Q85848881-0D8B0E7B-35A7-40A7-86D1-0F0A9ABA4FE7Q87655601-E0ECDA1A-BFD3-4158-9027-21EB42BC7EDCQ91973416-5A186F5C-2A9F-431C-86E5-E0ABE3E9C317Q92504474-983B89DC-BC1B-469D-BBDF-36ACBC49D236
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Valerio Chiurchiù
@en
Valerio Chiurchiù
@nl
type
label
Valerio Chiurchiù
@en
Valerio Chiurchiù
@nl
prefLabel
Valerio Chiurchiù
@en
Valerio Chiurchiù
@nl
P31
P496
0000-0002-0316-7311